$4.5 million behind new pill to tackle Australia’s number one killer

A new pill designed to reduce the devastating toll of heart disease and stroke around the world has received a $4.5 million boost, thanks to a joint venture between The George Institute and Bupa Australia & New Zealand. READ MORE

New Executive Director to lead The George Institute, China

World renowned clinician-scientist Professor Craig Anderson is the new Executive Director of The George Institute, China, taking over from Professor Zhi-Jie Zheng. READ MORE

Climate change may be causing chronic kidney disease

Climate change may be accelerating rates of chronic kidney disease caused by dehydration and heat stress, according to a paper in the prestigious Clinical Journal of the American Society of Nephrology. READ MORE

Launch of SmartGenRx and polypill

SmartGenRx is a new venture between The George Institute and Bupa Australia & New Zealand to develop innovative pharmaceutical products for critical health problems.

High blood pressure linked to vascular dementia

High blood pressure could significantly raise the risk of developing the second most common form of dementia, according to a new study. READ MORE

Research finds opioids are pain in the back

New research has found that opioid painkillers, a common treatment for low back pain, provide minimal benefit. READ MORE

Major global study identifies a safer treatment of acute stroke

A modified dosage of a controversial clot busting drug has been shown to reduce serious bleeding in the brain and improve survival rates of stroke patients. READ MORE

Selected media highlights

Award for Australia-India research excellence

The George Institute has won the “Excellence in Research and Development between Australia and India” award from the Australia India Business Council. READ MORE

"Because her wellbeing matters too..."

Executive Director of The George Institute, India, Professor Vivekanand Jha writes about gender equality in India. READ MORE

Study into blood pressure lowering named one of BMJ’s best of 2015

A study into the benefits of changing blood pressure lowering guidelines was shortlisted for UK Research Paper of the Year by the prestigious British Medical Journal. READ MORE

Roundtable: Better knowledge of pre-packaged food will help NCD management

The George Institute, China, has hosted a roundtable on Pre-packaged Food and Non-Communicable Diseases Prevention and Control, attended by researchers and members of government. READ MORE

George Clinical continues to expand its business development activities throughout the USA. This growth provides further evidence of the global trend towards conducting impactful clinical trials in the Asia-Pacific and engaging scientific leadership to manage them. READ MORE


Major global salt study going strong

Researchers in the five-year Salt Substitute and Stroke Study have met in Fengcheng of Liaoning province, a remote study site of the trial in northeastern China for their annual meeting. READ MORE

Medical Research Future Fund key to delivering a healthier Australia

The Medical Research Future Fund is an opportunity to catapult transformative change across the health system for the benefit of all Australians. READ MORE

Supporting Prevention 1st and greater investment in prevention

The George Institute commends the formation of the Prevention 1st Alliance; and echoes the call to Party Leaders to put preventative health policy first and act against the crisis of chronic disease affecting more than 1 in 2 Australians. READ MORE

in 2016


to date, up from 132 in April

The mission of The George Institute for Global Health is to improve the health of millions of people worldwide.
The George Institute e-newsletter
Copyright © 2016 The George Institute for Global Health, All rights reserved.

Update Subscription | Unsubscribe | Forward to a friend
Our mailing address is:

The George Institute for Global Health
Level 5, 1 King Street
Newtown, NSW 2042

Add us to your address book